icmf.fr
- Company typePrivate
- Founded2025
- HeadquartersMontpellier, France
- Headcount—
- GTM typeB2B
- OfferingServices
icmf.fr firmographics
Firmographics- Name
- icmf.fr
- Legal name
- ICMF - Institut des Cannabinoïdes Médicaux Français
- Website
- https://icmf.fr
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Ownership category
- akta.pro rank
icmf.fr industry classification
Industry- Product category
- Medical Cannabis Pharmaceutical R&D
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)
- akta.pro secondary industries
- Health Supply Chain, Procurement & Access to Medicines (BPADAIAI), Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)
Keywords
Where icmf.fr is headquartered
LocationHeadquarters
- HQ city
- Montpellier
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
icmf.fr business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Institutional Healthcare Services: Structure of scientific and technical knowledge around medical cannabinoids, supporting technology transfer and compliance with French regulatory framework. Operations appear to be healthcare institution-focused with public health orientation.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
icmf.fr product offering
Product offeringCore offering
ICMF structures technical and scientific knowledge around lipophilic active substances, including cannabinoids. The organization works on formulation platforms and pharmaceutical processes with international partners (Stenocare in Denmark, a Canadian GMP/BPF manufacturer, and Movianto in France for logistics), supports technology transfer and regulatory compliance within the French ANSM framework, and produces educational resources on the endocannabinoid system for healthcare professionals and patients.
Product overview
ICMF (Institut des Cannabinoïdes Médicaux Français) is a scientific and medical institute that structures technical and scientific knowledge around lipophilic active substances, including cannabinoids. The organization operates as an R&D and educational institute rather than a product manufacturer, focusing on formulation technologies and pharmaceutical processes for cannabinoids, technology transfer and compliance support within the French regulatory framework, and the production of educational resources on the endocannabinoid system. ICMF does not appear to offer distinct commercial product brands or named product offerings in the traditional sense; its offering consists of expertise, scientific knowledge structuring, and educational services related to medical cannabinoids.
Differentiator
Problem solved
Functional benefit
Companies that use icmf.fr
Customer profileSegments1 record
Ideal customer profiles3 records
icmf.fr technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
icmf.fr partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered major and core.
- La French CaremajorICMF is a member of La French Care, the movement federating healthcare system actors in France. Membership strengthens peer connections, event participation, and ICMF visibility within the ecosystem through responsible innovation serving patients.
- EurobiomedmajorICMF is a member of Eurobiomed, the health competitiveness cluster for South and Occitanie regions. The network facilitates partnerships, identifies funding opportunities, and provides support on key strategic issues.
- StenocarecoreStenocare (Denmark) holds SEDDS technology rights and collaborates with ICMF on formulation approaches for lipophilic active pharmaceutical ingredients including cannabinoids within a strictly institutional framework.
- Canadian Supplier and ManufacturercoreCanadian partner manufactures active pharmaceutical substances and formulations according to GMP/BPF pharmaceutical requirements, with quality control and regulatory documentation.
- MoviantocoreMovianto (France) serves as pharmaceutical operator and logistics partner, managing exploitation compliance and regulated distribution of health products with traceability and operational quality.
Scale indicators2 records
Recent moves2 records
Expansion highlights4 records
icmf.fr competitors and assessment
Company assessmentRegional players
- Boiron: French homeopathic pharmaceutical company with deep French pharmacy distribution and regulatory expertise. Comparable to ICMF as a French pharma operating through designated pharmacy networks under tight regulatory frameworks.
- Ethypharm: French specialty pharmaceutical company focused on drug formulation and hospital-channel products. Comparable to ICMF as a France-based specialty pharma operating in regulated hospital and pharmacy distribution with formulation expertise.
Emerging players
- Bedrocan: Dutch medical cannabis producer standardized for pharmaceutical-grade quality under government oversight. Comparable as a specialized producer with GMP-equivalent standards supplying regulated European medical cannabis markets.
Broad incumbents
- Canopy Growth: Global cannabis company with European medical cannabis operations through its Spectrum Therapeutics platform. Comparable as a broad incumbent operating in regulated medical cannabis channels and pursuing pharmaceutical-grade positioning.
- Aurora Cannabis: Major Canadian medical cannabis producer with European distribution operations. Comparable as a large-scale GMP medical cannabis supplier serving European hospital and pharmacy channels where ICMF also intends to operate.
- Jazz Pharmaceuticals (GW Pharmaceuticals): Global pharmaceutical company marketing FDA/EMA-approved cannabinoid medicines (Sativex, Epidiolex). Comparable to ICMF as the benchmark for pharmaceutical-grade cannabinoid drug commercialization within strict regulatory frameworks.
- Tilray: Large international medical cannabis producer with established European footprint including Germany and Portugal. Comparable to ICMF as a broad medical cannabis incumbent that operates GMP supply into hospital and pharmacy channels across regulated European markets.
Direct peers
- MediPharm Labs: GMP-certified pharmaceutical cannabis manufacturer focused on formulation and drug-delivery platforms. Comparable to ICMF because it occupies the upstream pharmaceutical-grade cannabinoid formulation space serving regulated international markets.
- Panaxia Pharmaceutical Industries: Israel-based pharma-grade medical cannabis manufacturer with proprietary formulation and drug-delivery platforms. Comparable to ICMF because it pairs GMP manufacturing with novel cannabinoid delivery technologies for regulated medical markets.
- Stenocare: Danish medical cannabis company and ICMF's direct SEDDS technology partner. Comparable because it is the IP holder for the formulation platform ICMF leverages and operates in the same institutional medical-cannabis pathway in Denmark.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
icmf.fr social profiles
Digital presenceicmf.fr financial estimates
Financial estimateRevenue estimate
Valuation estimate
icmf.fr leadership team
Management profileNumber of profiles
icmf.fr funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
icmf.fr M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about icmf.fr
What does icmf.fr do?
ICMF structures technical and scientific knowledge around lipophilic active substances, including cannabinoids. The organization works on formulation platforms and pharmaceutical processes with international partners (Stenocare in Denmark, a Canadian GMP/BPF manufacturer, and Movianto in France for logistics), supports technology transfer and regulatory compliance within the French ANSM framework, and produces educational resources on the endocannabinoid system for healthcare professionals and patients.
Is icmf.fr a public or private company?
icmf.fr is a private company. It is classified as unknown and is currently operating.
When was icmf.fr founded?
icmf.fr was founded in 2025.
Where is icmf.fr based?
icmf.fr is headquartered in Montpellier, France, in the Europe region.
How does icmf.fr make money?
One revenue line is on record: institutional Healthcare Services.
Who are icmf.fr's main competitors?
Regional players on record are Boiron and Ethypharm. Bedrocan is listed as an emerging player. Broad incumbents are Canopy Growth, Aurora Cannabis, Jazz Pharmaceuticals (GW Pharmaceuticals) and Tilray. Direct peers are MediPharm Labs, Panaxia Pharmaceutical Industries and Stenocare.
Does icmf.fr have an API?
No public API is recorded for icmf.fr.
What industry is icmf.fr in?
icmf.fr's product category is Medical Cannabis Pharmaceutical R&D. Its primary akta.pro industry code is HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC), with a secondary code of BPADAIAI, Health Supply Chain, Procurement & Access to Medicines. Its NAICS code is 3254 and its SIC code is 2834.